greeksoup/ stock research

Proto Labs (PRLB) Q1 FY2024 earnings: revenue $128 million, up 1.6% on the year

Proto Labs Inc. (PRLB) reported revenue of $128 million for Q1 FY2024, the quarter ended 31 March 2024, up 1.6% on the same quarter a year earlier. Net income was $5 million, up 98.1% on the year, and diluted earnings per share $0.20. The figures are the company's own, from the 10-Q it filed with the SEC on 3 May 2024.

Revenue$128 millionup 1.6%
Net income$5 millionup 98.1%
Diluted EPS$0.20
QuarterQ1 FY2024ended 31 March 2024

The quarter, against the one before and a year earlier

LineQ1 FY2024Q4 FY2023A year earlierChange on the year
Revenue128125n/an/a
Cost of revenue70.469.2n/an/a
Gross profit57.555.8n/an/a
Gross margin44.9%44.6%n/a
Research and development11.29.5n/an/a
Operating income6.88.4n/an/a
Operating margin5.3%6.7%n/a
Pre-tax income7.79.9n/an/a
Income tax2.52.9n/an/a
Effective tax rate31.8%29.7%n/a
Net income5.37.0n/an/a
Net margin4.1%5.6%n/a
Diluted EPS$0.20$0.27n/an/a
$ million except per share.
Read moreFourth quarters are the year less the first three quarters. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow and capital returned

LineQ1 FY2024Q4 FY2023A year earlierChange on the year
Operating cash flow21.317.2n/an/a
Capital expenditure2.618.2n/an/a
Free cash flow18.8-1.0n/an/a
Free cash flow margin14.7%-0.8%n/a
Cash from investing4.4-14.4n/an/a
Cash from financing-16.6-3.1n/an/a
Depreciation and amortisation9.19.3n/an/a
Share-based compensation4.34.2n/an/a
Buybacks16.04.9n/an/a
Diluted shares, weighted26m26mn/an/a
Shares outstanding at period end25m26mn/an/a

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet at quarter end

LineQ1 FY2024Q4 FY2023A year earlierChange on the year
Shareholders' equity687695n/an/a
Debt0.00.0n/an/a
Operating lease liabilities2.63.0n/an/a
Finance lease liabilities0.50.6n/an/a
Other liabilities79.473.5n/an/a
Total liabilities and equity770772n/an/a
Fixed assets248254n/an/a
Goodwill274274n/an/a
Intangible assets24.425.6n/an/a
Investments20.127.0n/an/a
Cash and equivalents92.883.8n/an/a
Receivables77.872.8n/an/a
Inventory12.813.7n/an/a
Other assets20.021.8n/an/a
Total assets770772n/an/a

Questions

What was Proto Labs' revenue in Q1 FY2024?

Proto Labs (PRLB) reported revenue of $128 million for Q1 FY2024, the quarter ended 31 March 2024, up 1.6% on the same quarter a year earlier.

How much did Proto Labs earn in Q1 FY2024?

Net income for Q1 FY2024 was $5 million, up 98.1% on the year, and diluted earnings per share $0.20.

When did Proto Labs report Q1 FY2024 results?

Proto Labs filed its 10-Q for the quarter ended 31 March 2024 with the SEC on 3 May 2024.

Quarterly results, the last 12 quarters

Q3 FY2023Q4 FY2023 *Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026
Revenue131125128126126122126135135136139149
Cost of revenue71.469.270.469.168.469.870.575.374.176.175.780.0
Gross profit59.355.857.556.557.252.055.759.861.360.463.669.3
Gross margin45%45%45%45%46%43%44%44%45%44%46%46%
R&D10.19.511.210.79.89.710.611.210.710.310.510.8
Operating income10.48.46.86.08.6-1.54.55.08.86.89.811.4
Operating margin8%7%5%5%7%-1%4%4%7%5%7%8%
Pre-tax income10.79.97.77.49.9-0.36.06.710.38.211.312.6
Tax rate26%30%32%38%27%n/a40%34%30%26%28%27%
Net income8.07.05.34.57.2-0.43.64.47.26.08.19.2
Net margin6%6%4%4%6%-0%3%3%5%4%6%6%
Diluted EPS$0.31$0.27$0.20$0.18$0.29-$0.01$0.15$0.18$0.30$0.25$0.33$0.37
Operating cash flow24.217.221.314.424.817.318.410.629.116.517.515.4
Capital expenditure3.118.22.64.21.60.81.31.54.18.13.56.2
Free cash flow21.1-1.018.810.223.216.517.19.125.08.414.09.2
Buybacks9.04.916.010.919.014.320.93.112.86.20.05.0
Shares outstanding26m26m25m25m25m24m24m24m24m24m24m24m
Filing10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS and diluted share count are from the company's results press release for that quarter, used where the release gives the same revenue and net income as the table. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

Source

10-Q for the period ended 31 March 2024, filed 3 May 2024, accession 0001628280-24-020233: the filing on EDGAR. All of Proto Labs Inc.'s filings: EDGAR company page.

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install